These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11342716)

  • 21. C5a mutants are potent antagonists of the C5a receptor (CD88) and of C5L2: position 69 is the locus that determines agonism or antagonism.
    Otto M; Hawlisch H; Monk PN; Müller M; Klos A; Karp CL; Köhl J
    J Biol Chem; 2004 Jan; 279(1):142-51. PubMed ID: 14570896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Site-specific mutations in the N-terminal region of human C5a that affect interactions of C5a with the neutrophil C5a receptor.
    Carney DF; Hugli TE
    Protein Sci; 1993 Sep; 2(9):1391-9. PubMed ID: 8401225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a.
    Wong AK; Finch AM; Pierens GK; Craik DJ; Taylor SM; Fairlie DP
    J Med Chem; 1998 Aug; 41(18):3417-25. PubMed ID: 9719594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The generation of stable CHO cell lines expressing very high levels of complement C5A receptors and subsequent modulation of binding affinity for C5A.
    Pease JE; Burton DR; Barker MD
    Biochem Mol Biol Int; 1993 Feb; 29(2):339-47. PubMed ID: 8495216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
    Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D
    Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation of glutamate 199 of the human C5a receptor defines a binding site for ligand distinct from the receptor N terminus.
    Monk PN; Barker MD; Partridge LJ; Pease JE
    J Biol Chem; 1995 Jul; 270(28):16625-9. PubMed ID: 7622471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells.
    Boulay F; Mery L; Tardif M; Brouchon L; Vignais P
    Biochemistry; 1991 Mar; 30(12):2993-9. PubMed ID: 2007135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel C5a receptor antagonists regulate neutrophil functions in vitro and in vivo.
    Pellas TC; Boyar W; van Oostrum J; Wasvary J; Fryer LR; Pastor G; Sills M; Braunwalder A; Yarwood DR; Kramer R; Kimble E; Hadala J; Haston W; Moreira-Ludewig R; Uziel-Fusi S; Peters P; Bill K; Wennogle LP
    J Immunol; 1998 Jun; 160(11):5616-21. PubMed ID: 9605167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Random mutagenesis of the complement factor 5a (C5a) receptor N terminus provides a structural constraint for C5a docking.
    Hagemann IS; Narzinski KD; Floyd DH; Baranski TJ
    J Biol Chem; 2006 Dec; 281(48):36783-92. PubMed ID: 17023413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Receptor activation by human C5a des Arg74 but not intact C5a is dependent on an interaction between Glu199 of the receptor and Lys68 of the ligand.
    Crass T; Bautsch W; Cain SA; Pease JE; Monk PN
    Biochemistry; 1999 Jul; 38(30):9712-7. PubMed ID: 10423250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Internalization and recycling of the C5a anaphylatoxin receptor: evidence that the agonist-mediated internalization is modulated by phosphorylation of the C-terminal domain.
    Naik N; Giannini E; Brouchon L; Boulay F
    J Cell Sci; 1997 Oct; 110 ( Pt 19)():2381-90. PubMed ID: 9410877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure of the complement factor 5a receptor-ligand complex studied by disulfide trapping and molecular modeling.
    Hagemann IS; Miller DL; Klco JM; Nikiforovich GV; Baranski TJ
    J Biol Chem; 2008 Mar; 283(12):7763-75. PubMed ID: 18195008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arginine 206 of the C5a receptor is critical for ligand recognition and receptor activation by C-terminal hexapeptide analogs.
    DeMartino JA; Konteatis ZD; Siciliano SJ; Van Riper G; Underwood DJ; Fischer PA; Springer MS
    J Biol Chem; 1995 Jul; 270(27):15966-9. PubMed ID: 7608153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probing the "message:address" sites for chemoattractant binding to the C5a receptor. Mutagenesis of hydrophilic and proline residues within the transmembrane segments.
    Kolakowski LF; Lu B; Gerard C; Gerard NP
    J Biol Chem; 1995 Jul; 270(30):18077-82. PubMed ID: 7629117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of wild-type and catalytically inactive forms of GRK2 and GRK6 fails to alter the agonist-induced phosphorylation of the C5a receptor (CD88): evidence that GRK6 is autophosphorylated in COS-7 cells.
    Milcent MD; Christophe T; Rabiet MJ; Tardif M; Boulay F
    Biochem Biophys Res Commun; 1999 May; 259(1):224-9. PubMed ID: 10334944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cloning and functional expression of the canine anaphylatoxin C5a receptor. Evidence for high interspecies variability.
    Perret JJ; Raspe E; Vassart G; Parmentier M
    Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):911-7. PubMed ID: 1472004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence that the extracellular N-terminal domain of C5aR contains amino-acid residues crucial for C5a binding.
    Mery L; Boulay F
    Eur J Haematol; 1993 Nov; 51(5):282-7. PubMed ID: 8282089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The amino terminus of the human C5a receptor is required for high affinity C5a binding and for receptor activation by C5a but not C5a analogs.
    DeMartino JA; Van Riper G; Siciliano SJ; Molineaux CJ; Konteatis ZD; Rosen H; Springer MS
    J Biol Chem; 1994 May; 269(20):14446-50. PubMed ID: 8182049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-function relationships of human C5a and C5aR.
    Huber-Lang MS; Sarma JV; McGuire SR; Lu KT; Padgaonkar VA; Younkin EM; Guo RF; Weber CH; Zuiderweg ER; Zetoune FS; Ward PA
    J Immunol; 2003 Jun; 170(12):6115-24. PubMed ID: 12794141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural diversity in the extracellular faces of peptidergic G-protein-coupled receptors. Molecular cloning of the mouse C5a anaphylatoxin receptor.
    Gerard C; Bao L; Orozco O; Pearson M; Kunz D; Gerard NP
    J Immunol; 1992 Oct; 149(8):2600-6. PubMed ID: 1401897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.